Mortality rate and morbidities associated with the surgical explantation of transcatheter aortic valve replacement (TAVR) valves are “not negligible,” and the potential risks should be considered in the lifetime management of aortic stenosis, researchers on one of the largest retrospective and prospective experience registries in the field found.